Total intravenous anesthesia with remifentanil, propofol and cisatracurium in end-stage renal failure

被引:24
|
作者
Dahaba, AA
von Klobucar, F
Rehak, PH
List, WF
机构
[1] Karl Franzens Univ Graz, Dept Anesthesiol & Intens Care Med, Graz, Austria
[2] Karl Franzens Univ Graz, Dept Surg, Biomed Engn & Comp Unit, Graz, Austria
关键词
D O I
10.1007/BF03013962
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Purpose: To compare recovery parameters of total intravenous anesthesia (TIVA) with remifentanil and propofol, hemodynamic responses to perioperative events, and pharmacodynamic parameters of cisatracurium in 22 end-stage renal failure and 22 normal renal function patients. Methods: Anesthesia was induced with 2-3 mg.kg(-1) propofol and 1 mu g.kg(-1) remifentanil and maintained with 75 mu g.kg(-1).min(-1) propofol and propofol initial infusion of 0.2 mu g.kg(-1).min(-1) propofol. Arterial pressure and heart rate were maintained by remifentanil infusion rate adjustments. The first twitch (TI) was maintained at 25% by an infusion-of cisatracurium. Results: There was no difference in the time to maintenance of adequate respiration, date of birth recollection, first analgesic administration, between the renal failure (4.8 +/- 2.5, 7.8 +/- 3.2, 12.3 +/- 5.3 min respectively) and the control group (5.2 +/- 2.8, 8.1 +/- 3.1, 12.7 +/- 5.5 min): nor were there any differences in the time to 25% TI recovery, TI recovery from 25% to 75%, or cisatracurium infusion rate between the renal failure group (32.1 +/- 10.8 min, 18.2 +/- 5.5 min; 0.89 +/- 0.29 mu g.kg(-1).min(-1) respectively) and the control group (35.9 (7.9 min, 18.4 +/- 3.8 min, 0.95 +/- 0.22 mu g.kg(-1).min(-1)). Conclusion: End-stage renal failure does not prolong recovery from TIVA with remifentanil and propofol, or the recovery from cisatracurium neuromuscular block.
引用
收藏
页码:696 / 700
页数:5
相关论文
共 50 条
  • [31] Uncontrolled high blood pressure under total intravenous anesthesia with propofol and remifentanil: A case report
    Min Jung Jang
    Jee Hee Kim
    Hae Jeong Jeong
    World Journal of Clinical Cases, 2022, (26) : 9411 - 9416
  • [32] Prospective evaluation of remifentanil-propofol mixture for total intravenous anesthesia: A randomized controlled study
    Bakan, Mefkur
    Umutoglu, Tarik
    Topuz, Ufuk
    Guler, Emine Yilmaz
    Uysal, Harun
    Ozturk, Erdogan
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (05)
  • [33] Accelerated idioventricular rhythm observed under total intravenous anesthesia using remifentanil, propofol, and rocuronium
    Nakanishi, Mika
    Masumo, Kaoru
    Oota, Takako
    Kato, Takeshi
    Imanishi, Toshihiro
    JA CLINICAL REPORTS, 2015, 1
  • [34] Remifentanil and propofol undergo separation and layering when mixed in the same syringe for total intravenous anesthesia
    O'Connor, Sean
    Zhang, Yan Ling
    Christians, Uwe
    Morrison, John E., Jr.
    Friesen, Robert H.
    PEDIATRIC ANESTHESIA, 2016, 26 (07) : 703 - 709
  • [35] Optimized Coadministration of Propofol and Remifentanil During the Induction Phase of Total Intravenous Anesthesia With Statistical Validation
    Huff, Daniel Denardi
    Fiacchini, Mirko
    Dang, Thao
    Alamo, Teodoro
    IEEE CONTROL SYSTEMS LETTERS, 2024, 8 : 193 - 198
  • [36] Accelerated idioventricular rhythm observed under total intravenous anesthesia using remifentanil, propofol, and rocuronium
    Mika Nakanishi
    Kaoru Masumo
    Takako Oota
    Takeshi Kato
    Toshihiro Imanishi
    JA Clinical Reports, 1 (1)
  • [37] Uncontrolled high blood pressure under total intravenous anesthesia with propofol and remifentanil: A case report
    Jang, Min Jung
    Kim, Jee Hee
    Jeong, Hae Jeong
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (26) : 9411 - 9416
  • [38] Infections in diabetes and end-stage renal failure
    Cheung, A
    Wong, L
    AMERICAN JOURNAL OF NURSING, 2002, 102 (08) : 17 - 17
  • [39] Quality of life in end-stage renal failure
    Petrova, N
    QUALITY OF LIFE RESEARCH, 1997, 6 (7-8) : 280 - 280
  • [40] Palliative rehabilitation in end-stage renal failure
    Alfred Wai Ping Seng
    Shuen-Loong Tham
    Renal Replacement Therapy, 8